Alan M. Miller

Reduced-Intensity Hematopoietic Cell Transplantation for Patients with Primary Myelofibrosis: A Cohort Analysis from the Center for International Blood and Marrow Transplant Research

Vikas Gupta, Adriana K. Malone, Parameswaran Hari et al. · Biology of Blood and Marrow Transplantation · 2013 · 145 citations · Full text

Medicine, Hematology, Immunology +17

Prospective Study of Sequential Reduction in Immunosuppression, Interferon Alpha-2B, and Chemotherapy for Posttransplantation Lymphoproliferative Disorder

Lode J. Swinnen, Michael LeBlanc, Thomas M. Grogan et al. · Transplantation · 2008 · 136 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease

Veronika Bachanová, D I Marks, M-J Zhang et al. · Leukemia · 2013 · 135 citations · Full text

Medicine, Immunology, Oncology +12

Improved survival after acute graft- <i>versus</i> -host disease diagnosis in the modern era

H. Jean Khoury, Tao Wang, Michael Hemmer et al. · Haematologica · 2017 · 109 citations · Full text

Medicine, Hematology, Oncology +13

Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome

Mary Jo Lechowicz, Hillard M. Lazarus, Joaquim Carreras et al. · Bone Marrow Transplantation · 2014 · 105 citations · Full text

Medicine, Hematology, Oncology +11